Navigation Links
BioMS Medical Announces Third Quarter 2009 Results
Date:11/12/2009

risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    BioMS Medical Corp.
    Interim Consolidated Balance Sheets
    (Unaudited)
    -------------------------------------------------------------------------

    (expressed in thousands of Canadian dollars)

                                                  September 30,  December 31,
                                                          2009          2008
                                                             $             $
                                                    (Unaudited)
    Assets

    Current assets
    Cash and cash equivalents                           53,622        87,826
    Short-term investments                               2,659         2,614
    Goods and services tax recoverable                     341           299
    Prepaid clinical trial costs                         2,482         2,227
    Recoverable from collaboration                       2,083           267
    Other current assets                                   120            54
                                                  ---------------------------

                                                        61,307        93,287

    Prepaid clinical trial costs                           
'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. BioMS Medical announces second quarter 2009 results
2. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
3. BioMS Medical to participate in panel session at Bio International Convention 2009
4. BioMS Medical Announces First quarter 2009 results
5. BioMS Medical to present at Alberta Economic Forum in Geneva
6. BioMS Medical to present at BioFinance 2009
7. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical Announces 2008 Year End Results
10. BioMS Medical warrant extension
11. BioMS Medical to present at BIO CEO and Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Diego, CA (PRWEB) December 18, 2014 ... a limited time special on Sartorius Biohit products ... Free on mLINE pipettes, Picus Electronic Pipette Trade-in Program, ... by Health and Safety officers around the world. They ... manual pipetting. Other features include:, ,     Full ...
(Date:12/19/2014)... NEW YORK , Dec. 18, 2014 ... novel therapies for the treatment of chronic pain, announced ... held today. "This was a transformational year ... a promising future for our company," said Sergio ... past year, we have executed on key financial, human ...
(Date:12/17/2014)... Achim Noack has been named global ... In this position, Noack will assist Jerry Stoller, CEO ... marketing strategy and supervise global marketing management and implementation ... tremendous knowledge and experience in the crop protection industry,” ... and innovative thinking will be a great asset for ...
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 2Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2
... Polytechnic Institute developed a new method for using water ... opening the door to new graphene-based transistors and nanoelectronics. ... Professor Nikhil Koratkar and his research team were able ... critical prerequisite to creating graphene transistors. At the heart ...
... Md., Oct. 26 MacroGenics, Inc., a leader ... that it has entered into a global research ... discover, develop and commercialize Dual-Affinity Re-Targeting (DART™) products ... technology is a proprietary, bi-specific antibody platform in ...
... parent company of Myeloma Health, a privately held predictive ... formation of their Scientific Advisory Board. They include: ... Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute ... Dr. Anderson of Dana-Farber Cancer Institute and ...
Cached Biology Technology:Water could hold answer to graphene nanoelectronics 2Water could hold answer to graphene nanoelectronics 3MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer 2MacroGenics Enters Global Research Collaboration and License Agreement with Pfizer 3Signal Genetics Announces Establishment of Scientific Advisory Board 2Signal Genetics Announces Establishment of Scientific Advisory Board 3
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/10/2014)... 9, 2014     ...   Jifflenow, a ... solutions for business-to-business (B2B) events, today announced a ... mobile near-field communication (NFC), Bluetooth low energy (BLE), ... http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate its ...
(Date:12/4/2014)... Fla. , Dec. 3, 2014  Crossmatch™, ... today announced that its DigitalPersona ® Pro ... readers have been deployed throughout First Bank branch ... South Carolina and Virginia. First ... Southern Pines, North Carolina , ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... multi-institution team of investigators led by researchers at the ... California (USC) has received $19 million in funding from ... groundbreaking effort to collect genetic information on tens of ... risks for schizophrenia and bipolar disorder. The ...
... be regarded as safe for pregnancy - other asthma drugs ... Women can usually keep using the same asthma drugs they ... best studied and can be regarded as safe. More trials ... German Institute for Quality and Efficiency in Health Care (IQWiG), ...
... easier than ever, but the amount of data to ... now shows that genome sequence analysis can be made ... massive amounts of data. Researchers from the ... Overall" for their entry at the Supercomputing ,08 High ...
Cached Biology News:USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 2USC researchers head global effort to study genetic risks that contribute to psychiatric diseases 3Pregnant women with asthma can be more confident about some medicines 2PNNL researchers earn top honors at Supercomputing conference 2PNNL researchers earn top honors at Supercomputing conference 3
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI RAT RT1Bu Immunogen: Rat thymocyte membrane glycoproteins...
... cloning of BAC (100+kb), fosmid (40kb), and ... stability than any othe BAC vector. On ... yields and easy recombinant DNA purification. Available ... (pSMART VC) vectors for the highest insert ...
SHEEP ANTI HUMAN ESTRONE...
Biology Products: